SEC Form 4 · accession 0000899866-15-000175
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Miller
Officer — SVP, Chief Compliance Officer
Period of report
Sep 9, 2015
Accepted (ET)
Sep 10, 2015 · 8:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | Sep 9, 2015 | S | 366 | $179.55 | D | 6,464 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.